Last Updated: July 26, 2026

CLINICAL TRIALS PROFILE FOR DORDAVIPRONE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for DORDAVIPRONE HYDROCHLORIDE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT06012929 ↗ A Study of ONC201 for Refractory Meningioma Not yet recruiting Chimerix Phase 1 2024-04-01 The goal of this clinical trial is to learn about treatment for a type of brain tumor called a meningioma. This study will enroll two groups of people. One group will be for people who will receive surgery to remove their brain tumor. The other group will be for people who have previously received treatment for their brain tumor but do not have any other available options for treatment. The primary goals of this study are: 1. To measure how much of the study drug is present in tumor tissue taken from patients during surgery to remove their brain tumor 2. To measure the length of time between a study participant's first dose of study treatment until the time when their brain tumor gets worse or their death
NCT06012929 ↗ A Study of ONC201 for Refractory Meningioma Not yet recruiting University of Nebraska Phase 1 2024-04-01 The goal of this clinical trial is to learn about treatment for a type of brain tumor called a meningioma. This study will enroll two groups of people. One group will be for people who will receive surgery to remove their brain tumor. The other group will be for people who have previously received treatment for their brain tumor but do not have any other available options for treatment. The primary goals of this study are: 1. To measure how much of the study drug is present in tumor tissue taken from patients during surgery to remove their brain tumor 2. To measure the length of time between a study participant's first dose of study treatment until the time when their brain tumor gets worse or their death
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for DORDAVIPRONE HYDROCHLORIDE

Condition Name

Condition Name for DORDAVIPRONE HYDROCHLORIDE
Intervention Trials
Meningioma 1
Refractory Meningioma 1
Relapsed Meningioma 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for DORDAVIPRONE HYDROCHLORIDE
Intervention Trials
Meningioma 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for DORDAVIPRONE HYDROCHLORIDE

Trials by Country

Trials by Country for DORDAVIPRONE HYDROCHLORIDE
Location Trials
United States 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for DORDAVIPRONE HYDROCHLORIDE
Location Trials
Nebraska 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for DORDAVIPRONE HYDROCHLORIDE

Clinical Trial Phase

Clinical Trial Phase for DORDAVIPRONE HYDROCHLORIDE
Clinical Trial Phase Trials
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for DORDAVIPRONE HYDROCHLORIDE
Clinical Trial Phase Trials
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for DORDAVIPRONE HYDROCHLORIDE

Sponsor Name

Sponsor Name for DORDAVIPRONE HYDROCHLORIDE
Sponsor Trials
Chimerix 1
University of Nebraska 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for DORDAVIPRONE HYDROCHLORIDE
Sponsor Trials
Industry 1
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial
Error:Operation timed out after 1000 milliseconds with 0 bytes received

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.